Full View

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

A Vijenthira, IY Gong, TA Fox, S Booth… - Blood, The Journal …, 2020 - ashpublications.org
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been
aggregated. The objective of this study was to perform a systematic review and meta …
被引用次数：605 相关文章

Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 patients.

A Vijenthira, IY Gong, TA Fox, S Booth, G Cook… - Blood, 2020 - dial.uclouvain.be
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been
aggregated. The objective of this study was to perform a systematic review and meta …
[PDF] academia.edu

[PDF][PDF] Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

J Razanamahery, JC Riches, J Zwicker, R Patell… - blood, 2020 - academia.edu
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been
aggregated. The objective of this study was to perform a systematic review and meta …
[HTML] sciencedirect.com

[HTML][HTML] Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

A Vijenthira, IY Gong, TA Fox, S Booth, G Cook… - Blood, 2020 - Elsevier
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been
aggregated. The objective of this study was to perform a systematic review and meta …

Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 patients

A Vijenthira, IY Gong, TA Fox, S Booth, G Cook… - Blood, 2020 - discovery.ucl.ac.uk
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been
aggregated. The objective of this study was to perform a systematic review and meta …

Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 patients

A Vijenthira, I Gong, T Fox, S Booth, G Cook, B Fattizzo… - BLOOD, 2020 - air.unimi.it
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been
aggregated. The objective of this study was to perform a systematic review and meta …

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

A Vijenthira, IY Gong, TA Fox, S Booth, G Cook… - Blood, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Outcomes for patients with hematologic
malignancy infected with COVID-19 have not been aggregated. The objective of this study …
[HTML] nih.gov

[HTML][HTML] Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

A Vijenthira, IY Gong, TA Fox, S Booth, G Cook… - Blood, 2020 - ncbi.nlm.nih.gov
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been
aggregated. The objective of this study was to perform a systematic review and meta …

Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 patients

A Vijenthira, IY Gong, TA Fox, S Booth, G Cook… - BLOOD, 2020 - iris.unisr.it
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been
aggregated. The objective of this study was to perform a systematic review and meta …
[PDF] researchgate.net

[PDF][PDF] Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

J Razanamahery, JC Riches, J Zwicker, R Patell… - blood, 2020 - researchgate.net
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been
aggregated. The objective of this study was to perform a systematic review and meta …